SCHEMBL22020165

SCHEMBL22020165

CC(C)(O)c1csc(S(N)(=O)=NC(N)=O)c1

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA2 P00918 8/20 0.36
KDM4E B2RXH2 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22020090 0.88 CA2 (0.40) CA2KDM4EGAA
SCHEMBL20680928 0.83 CA2 (0.36) CA2KDM4EGAA
SCHEMBL7144702 0.79 CA2 (0.51) CA2
SCHEMBL20692176 0.78 CA2 (0.34) CA2
SCHEMBL22013670 0.76 CA2 (0.38) CA2
SCHEMBL21810626 0.75 NLRP3 (0.47) CA2
SCHEMBL22021249 0.75 CA2 (0.34) CA2
SCHEMBL23482180 0.74 NLRP3 (0.36)
SCHEMBL26007201 0.74 NLRP3 (0.36)
SCHEMBL25085438 0.73 NLRP3 (0.45) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed